<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-56816" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Immunophenotyping</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Herold</surname>
            <given-names>Nicholas C.</given-names>
          </name>
          <aff>Univeristy of Central Florida</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mitra</surname>
            <given-names>Prasenjit</given-names>
          </name>
          <aff>All India Institute of Medical Sciences Jodhpur</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nicholas Herold declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prasenjit Mitra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-56816.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Immunophenotyping is a technique that couples specific antibodies to fluorescent compounds to measure specific protein expression within a cell population. The protein expression is used to identify and categorize the tagged cells. It is often used to measure CD4-T cell counts when attempting to study specific immunodeficiency disorders and immune-related diseases. Immunophenotyping is a type of flow cytometry testing in which the scattered light signals pick up the chosen fluorescent compounds to report the existence and expression of a target cell protein.<xref ref-type="bibr" rid="article-56816.r1">[1]</xref></p>
        <p>The ability of flow cytometry to determine the presence or absence of cell-surface markers serves as the basis of immunophenotyping. General targets such as CD56 can determine the level of natural killer cells, or more specific targets, such as CD45R combined with CD31, can explore T-cell subpopulations when attempting to narrow down categories of immunodeficiencies.<xref ref-type="bibr" rid="article-56816.r2">[2]</xref>&#x000a0;Immunophenotyping is a strong diagnostic tool that can be used in a wide variety of leukemias and immunodeficiency disorders. Immunophenotyping can also be used to further define cancer cell lines by exposing the presence or absence of cancer cell markers that correlate with different degrees of severity.<xref ref-type="bibr" rid="article-56816.r3">[3]</xref></p>
      </sec>
      <sec id="article-56816.s2" sec-type="Specimen Requirements and Procedure">
        <title>Specimen Requirements and Procedure</title>
        <p>When immunophenotyping for children, the use of a bone marrow sample for the first test is suggested, although subsequent tests can be run from a peripheral blood draw.<xref ref-type="bibr" rid="article-56816.r4">[4]</xref>&#x000a0;Peripheral blood draws can be used for the first round of immunophenotyping in adults. Samples collected from bone marrow aspiration and fine-needle aspiration are also options.<xref ref-type="bibr" rid="article-56816.r5">[5]</xref>&#x000a0;Blood storage should not be prolonged as it can cause selective loss of cell populations, such as neutrophils and eosinophils, due to their short half-life. Reagents such as Cyto-Chex and formaldehyde can extend the storage time of the blood while waiting to perform cytometry on the sample. When coupling immunophenotyping with flow cytometry, ethylene diamine tetra-acetate (EDTA) is the preferred anticoagulant. If the study is being done on granulocytes, in particular, heparin may be the anticoagulant of choice. Different laboratories may have slightly&#x000a0;varied protocols for sample collection and anticoagulant selection.<xref ref-type="bibr" rid="article-56816.r6">[6]</xref></p>
        <p>Following the collection of the sample, the target for the immunofluorescence marker is chosen. The target will vary depending on the reason for testing. Antibodies specific to the desired antigen are chosen to illuminate the antibody-antigen binding complex that is specific to the cell line of choice. The collected blood sample is washed with a lab purchased detergent such as Triton X-100, washed with a buffer, vortexed, and then placed in a centrifuge. The resulting pellet is then washed, resuspended in wash buffer, and then the epitope is stained and immediately analyzed on a flow cytometer.[6]</p>
      </sec>
      <sec id="article-56816.s3" sec-type="Diagnostic Tests">
        <title>Diagnostic Tests</title>
        <p>Immunophenotyping can be useful as a diagnostic test for a variety of diseases ranging from inherited immunodeficiencies to late-stage leukemia. It can also help support clinical diagnosis if the provider is unsure. Examples of diagnostic ability with target include but are not limited to:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute Myeloid Leukemia&#x000a0;<xref ref-type="bibr" rid="article-56816.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>Chronic Lymphocytic Leukemia:&#x000a0;<bold>CD20, CD22, CD23+, FMC-7-</bold></p>
          </list-item>
          <list-item>
            <p>Mantle Cell Lymphoma:<bold>&#x000a0;CD20, CD5+/-</bold></p>
          </list-item>
          <list-item>
            <p>Prolymphocytic Leukemia:&#x000a0;<bold>CD20 (+i), sIg (+i), FMC-7, CD5</bold></p>
          </list-item>
          <list-item>
            <p>Follicular Lymphoma&#x000a0;<bold>BCL-2, CD43</bold></p>
          </list-item>
          <list-item>
            <p>Diffuse Large B-Cell Lymphoma:<bold>&#x000a0;BCL-2, CD43&#x000a0;</bold></p>
          </list-item>
          <list-item>
            <p>Burkitt Lymphoma:&#x000a0;<bold>BCL-2,CD10 (+b), CD43</bold></p>
          </list-item>
          <list-item>
            <p>Hairy Cell Leukemia&#x000a0;<bold>CD20, CD22, CD11c, CD25, CD103, sIg (I)&#x000a0;</bold><xref ref-type="bibr" rid="article-56816.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Adult T-cell leukemia/lymphoma:&#x000a0;<bold>CD7, CD25&#x000a0;,HTLV-1</bold></p>
          </list-item>
          <list-item>
            <p>Natural Killer cells (cell differentiation):&#x000a0;<bold>CD57</bold></p>
          </list-item>
          <list-item>
            <p>Activated T cells:&#x000a0;<bold>CD25</bold></p>
          </list-item>
          <list-item>
            <p>T-cell large granular lymphocyte leukemia:&#x000a0;<bold>CD5, CD7,&#x000a0;CD16,&#x000a0;granzyme-B, perforin, CD56</bold></p>
          </list-item>
          <list-item>
            <p>Eosinophilic Otitis Media:&#x000a0;<bold>Eosinophils&#x000a0;</bold><xref ref-type="bibr" rid="article-56816.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Multiple Myeloma:&#x000a0;<bold>Plasma Cells&#x000a0;</bold><xref ref-type="bibr" rid="article-56816.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Common Variable Immunodeficiency:&#x000a0;<bold>CD21, CD40L</bold>&#x000a0;<xref ref-type="bibr" rid="article-56816.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Leukocyte adhesion deficiency (LAD) type 1:&#x000a0;<bold>CD18, CD11b, CD11c&#x000a0;</bold><xref ref-type="bibr" rid="article-56816.r2">[2]</xref></p>
          </list-item>
          <list-item>
            <p>Non-small cell lung cancer:&#x000a0;<bold>PD-L1&#x000a0;</bold><xref ref-type="bibr" rid="article-56816.r12">[12]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-56816.s4" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>Due to the relatively new use of flow cytometry for immunophenotyping, there are several interfering factors:</p>
        <list list-type="bullet">
          <list-item>
            <p>Poor standardization regarding the choice of reagents</p>
          </list-item>
          <list-item>
            <p>How to prepare and store cells to be analyzed</p>
          </list-item>
          <list-item>
            <p>How to analyze the collected data</p>
          </list-item>
        </list>
        <p>Recent attempts have been made to investigate each of the variables that stands as a roadblock for standardization; notably, many are assembled in &#x0201c;Guidelines for the use of flow cytometry and cell sorting in immunological studies,&#x0201d; published in the European Journal of Immunology.<xref ref-type="bibr" rid="article-56816.r3">[3]</xref></p>
      </sec>
      <sec id="article-56816.s5" sec-type="Results, Reporting, and Critical Findings&#x0000d;&#x0000a;">
        <title>Results, Reporting, and Critical Findings
</title>
        <p>Results of immunophenotyping and critical findings may vary with age. Reliable reference values are necessary for accurate reporting, and when using immunophenotyping, especially for primary immunodeficiencies, adjusting to lymphocyte count by age is necessary. From birth to 18 years, lymphocyte count trends down, lymphocyte count in a neonate with an immunodeficiency may appear similar to a healthy 18-year-old. Further, the breakdown of lymphocyte subsets fluctuates with age. Both changes must be taken into consideration when determining if the laboratory values for younger individuals are normal or represent critical findings for their age category.<xref ref-type="bibr" rid="article-56816.r13">[13]</xref>&#x000a0;</p>
        <p>Age-specific reference values are relatively scarce, which can cause misdiagnosis as immunophenotyping becomes more widespread for the diagnosis of childhood primary immunodeficiencies. Reporting and normal lab values will differ for each cell line and surface protein that is investigated.</p>
      </sec>
      <sec id="article-56816.s6" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Immunophenotyping and its ability to identify specific cell lineages allow for the direct diagnosis of many immunodeficiency disorders in children as well as cancers of all ages. In some cases, it can be used as an aid to diseases that are traditionally clinical diagnosis if the clinician is unsure the diagnosis is correct. When used as a clinical test, immunophenotyping is a non-invasive way to investigate the type and cause of specific immunodeficiency subtypes. Immunophenotyping can also be used prior to immunotherapy to determine if the therapy target is available in the cancer cell line. Creating a profile of the cancer cell line with immunophenotyping, is necessary to determine which therapies, if any, will benefit the patient.<xref ref-type="bibr" rid="article-56816.r12">[12]</xref>&#x000a0;Clinical use of immunophenotyping is not limited to use in human populations, with studies showing it can help to predict survival time in dogs afflicted with chronic lymphocytic leukemia (CLL). Its use in predicting the severity of CLL in humans has been established, and it appears the results are similar in dogs.<xref ref-type="bibr" rid="article-56816.r14">[14]</xref>&#x000a0;</p>
        <p>Although not as common as immunophenotyping&#x000a0;with&#x000a0;blood and bone marrow, samples can also be obtained from cerebrospinal fluid. Cerebrospinal fluid immunophenotyping via flow cytometry can compare T-cell populations as well as the CD4: CD8 ratio within the cerebrospinal fluid, expanding the scope of immunophenotyping as a diagnostic tool.<xref ref-type="bibr" rid="article-56816.r15">[15]</xref>&#x000a0;Flow cytometry immunophenotyping also has a role to play in the detection of minimal residual disease after the treatment of adult and pediatric lymphoblastic leukemia. It allows clinicians to detect aberrant leukemia-specific antigens that coincide with possible disease recurrence.<xref ref-type="bibr" rid="article-56816.r16">[16]</xref></p>
      </sec>
      <sec id="article-56816.s7" sec-type="Quality Control and Lab Safety&#x0000d;&#x0000a;">
        <title>Quality Control and Lab Safety
</title>
        <p>The increasing use of mass cytometry-based immunophenotyping requires increased reproducibility of experiments and normalization of protocols between various labs. Current trends work to increase reproducibility and decrease technical variations. This goal is achievable with the use of a consistent reference sample from a single blood donation to mimic stable population frequencies. The use of mass cytometry for phenotyping creates more separation between negative and positive populations when compared to using it to determine the functional characteristics of cells. To increase quality control when investigating functional characteristics, the use of semi-automated &#x0201c;tethered&#x0201d; gating approaches (FlowJo) when analyzing data provides superior quality control compared to the fully automated methods (SPADE, viSNE) algorithms which are superior for phenotyping.<xref ref-type="bibr" rid="article-56816.r17">[17]</xref></p>
        <p>The mapping of the human immune system termed the &#x0201c;Human Immunology Project,&#x0201d; pushes for &#x0201c;measurement of variations in the human immune system.&#x0201d; To meet this goal, the project is pushing for standardizing assays to distinguish true variation from the artifact. The project pushes for quality control through the reduction of diversity of reagents, &#x0201c;definitions of standard antibody panels for immunophenotyping, point-of collection automation of sample processing, setting the fluorescence of standard beads to defined target channels for reproducible setup across instruments, central analysis by one of few coordinated experts and use of automated gating algorithms.&#x0201d;<xref ref-type="bibr" rid="article-56816.r18">[18]</xref> Currently, even well-studied cell lines are defined differently in studies making standardization difficult.</p>
      </sec>
      <sec id="article-56816.s8">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=56816&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=56816">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/56816/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=56816">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-56816.s9">
        <title>References</title>
        <ref id="article-56816.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bleesing</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Fleisher</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Immunophenotyping.</article-title>
            <source>Semin Hematol</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>100</fpage>
            <page-range>100-10</page-range>
            <pub-id pub-id-type="pmid">11309692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delmonte</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Fleisher</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Flow cytometry: Surface markers and beyond.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>143</volume>
            <issue>2</issue>
            <fpage>528</fpage>
            <page-range>528-537</page-range>
            <pub-id pub-id-type="pmid">30170120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cossarizza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Radbruch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Akdis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Andr&#x000e4;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Annunziato</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bacher</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Barnaba</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Battistini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Baumgart</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Becher</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Beisker</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Berek</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Blanco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Borsellino</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Boulais</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Brinkman</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>B&#x000fc;scher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Busch</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Bushnell</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cavani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chattopadhyay</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Clerici</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cooke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cosma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cosmi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cumano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dang</surname>
                <given-names>VD</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>De Biasi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Del Zotto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Della Bella</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dellabona</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Deniz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dessing</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Diefenbach</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Di Santo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dieli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dolf</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Donnenberg</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>D&#x000f6;rner</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ehrhardt</surname>
                <given-names>GRA</given-names>
              </name>
              <name>
                <surname>Endl</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Engel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Engelhardt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Esser</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Everts</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dreher</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Falk</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Fehniger</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Filby</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fillatreau</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Follo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>F&#x000f6;rster</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Foulds</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Frenette</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Galbraith</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Garbi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Godoy</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Geginat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ghoreschi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gibellini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Goettlinger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Goodyear</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Gori</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grogan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gr&#x000fc;tzkau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grummitt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hammer</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Hauser</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Haviland</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Hedley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Herrera</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Herrmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hiepe</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hombrink</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Houston</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hoyer</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hunter</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Iannone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>J&#x000e4;ck</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>J&#x000e1;vega</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jonjic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Juelke</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaiser</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kalina</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kienh&#x000f6;fer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kroneis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kunkel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kurts</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kvistborg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lannigan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lantz</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Larbi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>LeibundGut-Landmann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leipold</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Levings</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Litwin</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lohoff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lombardi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lovett-Racke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lubberts</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ludewig</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lugli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Maecker</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Martrus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Matarese</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mauer&#x000f6;der</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McInnes</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mei</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Melchers</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Melzer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mielenz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mills</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mirrer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mj&#x000f6;sberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Moretta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moretta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mosmann</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>M&#x000fc;nz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Multhoff</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Munoz</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Nakayama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nasi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neud&#x000f6;rfl</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nolan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nourshargh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ouyang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Oxenius</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Palankar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Panse</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Peth</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Petriz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Philips</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pickl</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Piconese</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pinti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pockley</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Podolska</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Pucillo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Quataert</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Radstake</surname>
                <given-names>TRDJ</given-names>
              </name>
              <name>
                <surname>Rajwa</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rebhahn</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Recktenwald</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Remmerswaal</surname>
                <given-names>EBM</given-names>
              </name>
              <name>
                <surname>Rezvani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rico</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Romagnani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rubartelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ruckert</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ruland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sakaguchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sala-de-Oyanguren</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Samstag</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sanderson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sawitzki</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Scheffold</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schiemann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schildberg</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schimisky</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schmid</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Schmitt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schober</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sch&#x000fc;ler</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schulz</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Schumacher</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Scotta</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shankey</surname>
                <given-names>TV</given-names>
              </name>
              <name>
                <surname>Shemer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Spidlen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stall</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Stehle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Steinmetz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Stockinger</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takahama</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tarnok</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Toldi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tornack</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Traggiai</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Trotter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ulrich</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>van der Braber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Lier</surname>
                <given-names>RAW</given-names>
              </name>
              <name>
                <surname>Veldhoen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vento-Asturias</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vieira</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Voehringer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Volk</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>von Volkmann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Waisman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Warnatz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Warth</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Watzl</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wegener</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wiedemann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wienands</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Willimsky</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wing</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wurst</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yue</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ziegler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zimmermann</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Guidelines for the use of flow cytometry and cell sorting in immunological studies.</article-title>
            <source>Eur J Immunol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>47</volume>
            <issue>10</issue>
            <fpage>1584</fpage>
            <page-range>1584-1797</page-range>
            <pub-id pub-id-type="pmid">29023707</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dworzak</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Buldini</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gaipa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ratei</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hrusak</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Luria</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rosenthal</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bourquin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Sartor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schumich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karawajew</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mejstrikova</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Maglia</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Biondi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schrappe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Basso</surname>
                <given-names>G</given-names>
              </name>
              <collab>International-BFM-FLOW-network</collab>
            </person-group>
            <article-title>AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia.</article-title>
            <source>Cytometry B Clin Cytom</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>94</volume>
            <issue>1</issue>
            <fpage>82</fpage>
            <page-range>82-93</page-range>
            <pub-id pub-id-type="pmid">28187514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akanni</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Palini</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Immunophenotyping of Peripheral Blood and Bone Marrow Cells by Flow Cytometry.</article-title>
            <source>EJIFCC</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-21</page-range>
            <pub-id pub-id-type="pmid">29795718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diks</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bonroy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Teodosio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Groenland</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>de Mooij</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>de Maertelaere</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Neirynck</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Philipp&#x000e9;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Orfao</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Dongen</surname>
                <given-names>JJM</given-names>
              </name>
              <name>
                <surname>Berkowska</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Impact of blood storage and sample handling on quality of high dimensional flow cytometric data in multicenter clinical research.</article-title>
            <source>J Immunol Methods</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>475</volume>
            <fpage>112616</fpage>
            <pub-id pub-id-type="pmid">31181213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cherian</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis.</article-title>
            <source>Clin Lab Med</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>753</fpage>
            <page-range>753-769</page-range>
            <pub-id pub-id-type="pmid">29128067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Craig</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Foon</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Flow cytometric immunophenotyping for hematologic neoplasms.</article-title>
            <source>Blood</source>
            <year>2008</year>
            <month>Apr</month>
            <day>15</day>
            <volume>111</volume>
            <issue>8</issue>
            <fpage>3941</fpage>
            <page-range>3941-67</page-range>
            <pub-id pub-id-type="pmid">18198345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saliba</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Alzahrani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Bestavros</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic otitis media diagnosis using flow cytometric immunophenotyping.</article-title>
            <source>Acta Otolaryngol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>138</volume>
            <issue>2</issue>
            <fpage>110</fpage>
            <page-range>110-115</page-range>
            <pub-id pub-id-type="pmid">29037099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vergnolle</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rieu</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Avet-Loiseau</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Corre</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vergez</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>[Multiple myeloma immunophenotyping: method validation].</article-title>
            <source>Ann Biol Clin (Paris)</source>
            <year>2019</year>
            <month>Apr</month>
            <day>01</day>
            <volume>77</volume>
            <issue>2</issue>
            <fpage>197</fpage>
            <page-range>197-217</page-range>
            <pub-id pub-id-type="pmid">30998199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wehr</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kivioja</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schmitt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ferry</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Witte</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eren</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vlkova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Detkova</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bos</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Poerksen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>von Bernuth</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Baumann</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Goldacker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gutenberger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schlesier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bergeron-van der Cruyssen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Le Garff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Debr&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bateman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Litzman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van Hagen</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Thon</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Quinti</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Espanol</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Webster</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Chapel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vihinen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oksenhendler</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Peter</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Warnatz</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The EUROclass trial: defining subgroups in common variable immunodeficiency.</article-title>
            <source>Blood</source>
            <year>2008</year>
            <month>Jan</month>
            <day>01</day>
            <volume>111</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-85</page-range>
            <pub-id pub-id-type="pmid">17898316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wojas-Krawczyk</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kalinka</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Grenda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krawczyk</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Milanowski</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Beyond PD-L1 Markers for Lung Cancer Immunotherapy.</article-title>
            <source>Int J Mol Sci</source>
            <year>2019</year>
            <month>Apr</month>
            <day>18</day>
            <volume>20</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">31003463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tosato</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bucciol</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pantano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Putti</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Sanzari</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Basso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Plebani</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytes subsets reference values in childhood.</article-title>
            <source>Cytometry A</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>87</volume>
            <issue>1</issue>
            <fpage>81</fpage>
            <page-range>81-5</page-range>
            <pub-id pub-id-type="pmid">25132325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Comazzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gelain</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Martini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Riondato</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Miniscalco</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Marconato</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Stefanello</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mortarino</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Immunophenotype predicts survival time in dogs with chronic lymphocytic leukemia.</article-title>
            <source>J Vet Intern Med</source>
            <year>2011</year>
            <season>Jan-Feb</season>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>100</fpage>
            <page-range>100-6</page-range>
            <pub-id pub-id-type="pmid">21092008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>H&#x000fc;mmert</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Alvermann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gingele</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Wiendl</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mirenska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hennig</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stangel</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Immunophenotyping of cerebrospinal fluid cells by Chipcytometry.</article-title>
            <source>J Neuroinflammation</source>
            <year>2018</year>
            <month>May</month>
            <day>25</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>160</fpage>
            <pub-id pub-id-type="pmid">29801453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schrappe</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Minimal residual disease: optimal methods, timing, and clinical relevance for an individual patient.</article-title>
            <source>Hematology Am Soc Hematol Educ Program</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>137</fpage>
            <page-range>137-42</page-range>
            <pub-id pub-id-type="pmid">23233572</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kleinsteuber</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Corleis</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rashidi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nchinda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lisanti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Medoff</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Standardization and quality control for high-dimensional mass cytometry studies of human samples.</article-title>
            <source>Cytometry A</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>89</volume>
            <issue>10</issue>
            <fpage>903</fpage>
            <page-range>903-913</page-range>
            <pub-id pub-id-type="pmid">27575385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-56816.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maecker</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>McCoy</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Standardizing immunophenotyping for the Human Immunology Project.</article-title>
            <source>Nat Rev Immunol</source>
            <year>2012</year>
            <month>Feb</month>
            <day>17</day>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>191</fpage>
            <page-range>191-200</page-range>
            <pub-id pub-id-type="pmid">22343568</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
